Skip to main content
. 2018 Jan 26;25(2):133–138. doi: 10.1097/GME.0000000000000985

FIG. 2.

FIG. 2

Mean (±SD) change from baseline in self-assessed severity of dyspareunia (A), vaginal irritation/itching (B), and vaginal dryness (C; mITT Population). Dyspareunia, vaginal/vulvar irritation/itching, and vaginal dryness, severity scores: 0 = none, 1 = mild, 2 = moderate, 3 = severe. Data for final assessment for vaginal dryness was a coprimary endpoint and is reported in Table 2 above. ∗∗∗P < 0.001; ∗∗P < 0.01; panels A and C; vs estradiol, panel B. mITT, modified intent-to-treat.